Skip to content
healthcare.dev

Alendronate Sodium

NDC 64980-341, Alendronate Sodium, tablet, from Rising Pharma Holdings, Inc..

Product NDC
64980-341
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090124
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/64980-341 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALENDRONATE SODIUM35 mg/1

Pharmacologic classes

Bisphosphonate [EPC]; Diphosphonates [CS]

Package NDCNDC-11Package
64980-341-12649800341123 BLISTER PACK in 1 CARTON (64980-341-12) / 4 TABLET in 1 BLISTER PACK
64980-341-14649800341141 BLISTER PACK in 1 CARTON (64980-341-14) / 4 TABLET in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ffdd2496-d253-419b-85a6-8c615f7545f1
  • NADAC price for package 64980034114

    GET /v1/drugs/nadac/64980034114

Use it

Look up 64980-341 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/64980-341 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 64980-341. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.